Chemotherapy activates inflammasomes to cause inflammation-associated bone loss
elifesciences.org
be elucidated. Using tumor-free mouse models, which are commonly used to assess direct off-target effects of anti-neoplastic therapies, Thus, we found that inflammasomes are key players in bone loss caused by doxorubicin
1 Users
0 Comments
2 Highlights
0 Notes
Top Highlights
- be elucidated. Using tumor-free mouse models, which are commonly used to assess direct off-target effects of anti-neoplastic therapies,
- Thus, we found that inflammasomes are key players in bone loss caused by doxorubicin
Domain
Ready to highlight and find good content?
Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.